BackJupiter Wellness Acquisition - Tradeable Rights - Dec 2026 Overview

Jupiter Wellness Acquisition - Tradeable Rights - Dec 2026 EBIT

Jupiter Wellness Acquisition - Tradeable Rights - Dec 2026's EBIT is $-300K, above the sector sector average of $-77M.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$252.42K
5.6% YoY

As of Mar 31, 2023

Annual EBIT (TTM)

-$296.25K

Trailing 12 months ending Mar 31, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jupiter Wellness Acquisition - Tradeable Rights - Dec 2026 (JWACR) FAQ

The latest EBIT for JWACR is $-300K as of March 2023. That is above the sector sector average of $-77M. Investors often review this figure alongside Jupiter Wellness Acquisition - Tradeable Rights - Dec 2026's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, JWACR currently prints $-300K for EBIT, while the sector average sits near $-77M. That is roughly 99.6% above the sector mean. Large gaps often invite a closer look at Jupiter Wellness Acquisition - Tradeable Rights - Dec 2026's growth, margins, and balance sheet.

A EBIT figure of $-300K for JWACR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-77M. Explore the charts below for those layers of context.

After noting JWACR's EBIT ($-300K), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.